Search This Blog

Wednesday, August 7, 2019

Collegium Pharmaceutical EPS beats by $0.05, misses on revenue

Collegium Pharmaceutical (NASDAQ:COLL): Q2 GAAP EPS of -$0.14 beats by $0.05.
Revenue of $75.04M (+2.7% Y/Y) misses by $0.73M.
Shares -2.26%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)